Lactobacillus
|
Lactobacillus acidophilus
|
Used in the treatment of diarrhea and for relief from the symptoms of irritable bowel syndrome; can reduce cytokines to relieve inflammatory bowel disease, modulate immunity, lower cholesterol, relieve diarrhea, and alleviate cancer. |
[36,37,38] |
Lacticaseibacillus casei
|
Prevention or treatment of diseases that disrupt the intestinal microbiota: diarrhea and constipation, relief from the symptom of irritable bowel syndrome, and gingivitis, and the anti-inflammatory response. |
[39,40,41,42] |
Lactobacillus rhamnosus
|
Has anti-diabetic and anti-viral activity; used to treat obesity; has the ability to fight against pathogenic bacteria and fungi in the genitourinary tract, preventing the recurrence of urinary tract infections in postmenopausal women; prevents enteric colonization by Candida species and treats recurrent Clostridium difficile-induced colitis in children; and has an effect on symptoms of maternal depression and anxiety during the postpartum period. |
[43,44,45,46,47,48] |
Lactiplantibacillus plantarum
|
Has the ability to prevent the production of endotoxin; improves of the symptom of irritable bowel; and has antimicrobial activity and cholesterol lowering activity. |
[49,50] |
Lactobacillus reuteri
|
Treatment of gingivitis in pregnant women and chronic periodontitis. |
[50,51,52,53,54] |
Bifidobacterium
|
Bifidobacterium infantis
|
Can improve the symptoms of irritable bowel syndrome and inhibits the secretion of allergen induced IgE. |
[55,56,57,58] |
Bifidobacterium adolescentis
|
Can reduce inflammation of the spleen and brain and changes the microbiota of cecum and colon. |
[59] |
Bifidobacterium bifidum
|
Can reduce cholesterol; is used in the treatment of infant diarrhea; and has greater cytokine (IL-6) production and active phagocytic properties. |
[60,61,62] |
Bifidobacterium longum
|
Used in treating diarrhea and provides relief from the symptoms of irritable bowel syndrome; modulates the immune system through IL-10 production. |
[63,64] |
Other Lactic Acid Bacteria
|
Streptococcus thermophilus
|
Can produce antioxidant compounds and mitigate the risk of some types of cancer; has anti-inflammatory, antimutagenic effects and stimulates the gut immune system; and is useful in inflammatory bowel disease. |
[65,66] |
Enterococcus faecium
|
Modulates the Th2-mediated pathologic response. |
[67,68] |
Other Microorganisms
|
Bacillus subtilis
|
Used in treating diarrhea, in the eradication of H. pylori, and in the production of vitamin K. |
[69,70] |
Bacillus coagulans
|
Can regulate the balance of intestinal microbiota and improve immunity; promotes the metabolism and utilization of nutrients; and is able to resist high temperatures and has acid and bile resistance. |
[71,72,73] |
Saccharomyces boulardi
|
Used in treating diarrhea, ulcerative colitis, and a symptom of irritable bowel syndrome. |
[74,75,76] |
|
Escherichia coli NISSLE 1917
|
Used in the treatment of intestinal diseases (diarrhea, inflammatory bowel disease, ulcerative colitis); can exhibit antagonistic effects on a variety of intestinal pathogenic bacteria; regulates the secretion of immune factors in vivo; and enhances the ability of host immunity. |
[77,78,79] |